Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Allscripts Healthcare Solutions Inc (MDRX) Rallies On Strong Preliminary Q2 Results

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) shares have rallied over 10% today following a forecast by the company that it will have better-than-expected results for its second quarter earnings, which are scheduled to be reported on August 4. The information technology and services firm, which caters mostly to the healthcare sector, said that it expects to report adjusted earnings of $0.12 per share, up from $0.09 per share in the year-ago period, on revenues of $350 million to $353 million, compared to its $351 million in revenues in the second quarter of last year. GAAP loss per share is expected by the company to be about $0.01 per share, down from a loss per share of $0.09 in the comparable year-ago quarter. Wall Street is expecting the firm to report earnings of $0.10 per share on revenues of $347 million. Meanwhile, for the second quarter, Allscripts also revealed that it expects to report bookings in the $255 million to $260 million range, a record for the second quarter, and a growth of between 9% and 12 year-over-year.Allscripts Healthcare Solutions Inc (MDRX), NASDAQ:MDRX, Yahoo Finance,

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) President and Chief Executive Officer Paul M. Black explained in a statement that, “Sales growth in the second quarter accelerated compared with the first quarter based on improving performance within acute and international markets. Ambulatory solutions and growth in Allscripts payer and life sciences business helped drive the year-over-year bookings growth. Revenue improved on a sequential basis, driven by growth in both recurring and non-recurring revenue.”

Heading into the second quarter, a total of 28 of the hedge funds tracked by Insider Monkey held long positions in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), up from 24 one quarter earlier. However, the total value of the holdings of those funds which held long positions by the end of the first quarter decreased by 11.55% compared to the previous quarter, to $471.34 million. This was slightly offset, nonetheless, by a 6.34% decline in the stock’s value from January 2 to March 31. The stock grew by 14.38% in the second quarter.

At Insider Monkey, we track hedge funds’ moves in order to identify actionable patterns and profit from them. Our research has shown that hedge funds’ large-cap stock picks historically delivered a monthly alpha of six basis points, though these stocks underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012. On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month (read the details here). Since the official launch of our small-cap strategy in August 2012, it has performed just as predicted, returning over 139% and beating the market by more than 80 percentage points. We believe the data is clear: investors will be better off by focusing on small-cap stocks utilizing hedge fund expertise rather than large-cap stocks.

Insider Monkey also looks at insider trades, be they sales or purchases, to gauge insider sentiment on their own firms’ stocks. However, Allscripts Healthcare Solutions insiders have not made any purchases or sales so far this year.

Bearing all of these in mind, let’s view the new hedge fund activity concerning Allscripts Healthcare Solutions Inc.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.